AdvertiseDonate
LatestPresident Herzog warns Netanyahu of severe consequences from unchecked settler violence
GreensboroWinston-SalemDurhamRaleighCharlotteRichmondChesapeakeVirginia Beach
Thursday, November 5, 2026News you can follow.
Current Column · 7B Corporate Center Court, Greensboro, NC 27408
News · Greenville

Doctor Calls New Hemorrhage Treatment Better Than Blood

A University of Missouri-Kansas City researcher is testing a grocery list ingredient as a substitute for transfusions in severe trauma cases.

By Maya Morris ·

Illustration for: Doctor Calls New Hemorrhage Treatment Better Than Blood
Illustration generated for this article, not a news photograph.

Hospital blood banks face a constant challenge in sourcing enough plasma for trauma patients. One researcher in Kansas City believes a common food ingredient can help solve that problem.

A doctor and research scientist at the University of Missouri-Kansas City says he has discovered a potential alternative to blood transfusions for people with severe blood loss. He describes the treatment as better than blood. The goal is to stop hemorrhagic shock, a condition that can kill a patient in minutes after a car crash or gunshot wound.

Currently, a blood transfusion is the standard of care for stopping severe bleeding. The new approach uses ingredients that are already on most grocery lists. The researcher is testing how these components interact with the body to stabilize patients who are bleeding out.

Medical experts in the community are watching the tests with hope. They believe this discovery could ease the pressure on local blood donation drives. If the treatment proves effective in human trials, it could change how emergency rooms treat critical injuries.

The research is still in the testing phase. The doctor is gathering data to see if the new method works as well as traditional transfusions. He is not yet recommending it as a replacement for all blood products, but he says the early results are promising.

The project aims to create a supply of life-saving treatment that does not rely on a steady stream of human donors. This is a critical issue for hospitals in urban centers like Kansas City, where demand for blood often outpaces supply during busy seasons.

The researcher will continue to monitor the safety and efficacy of the ingredient in the coming trials. He plans to publish his findings once the data is complete. For now, the treatment remains an experimental option for severe trauma patients.

Source: FOX Carolina

More News · Report a business · Got a Story?

Get Current Column in your inboxNews you can follow. Free, a few times a week, unsubscribe any time.

Related stories

Get Current Column in your inboxNews you can follow. Free, a few times a week, unsubscribe any time.